Cargando…

Clinical Influence of Ethanol Infusion in the Vein of Marshall on Left Atrial Appendage Occlusion: Results of Feasibility and Safety during Implantation and at 60-Day Follow-Up

Background: Ethanol infusion in the vein of Marshall (EI-VOM) has the advantages of reducing the burden of atrial fibrillation (AF), decreasing AF recurrence, and facilitating left pulmonary vein isolation and mitral isthmus bidirectional conduction block. Moreover, it can lead to prominent edema of...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Yibo, Hu, Miaoyang, Guo, Lanyan, Xu, Jian, Li, Jie, Yan, Qun, Pang, Huani, Wang, Jinshui, Yang, Ping, Yi, Fu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10004188/
https://www.ncbi.nlm.nih.gov/pubmed/36902746
http://dx.doi.org/10.3390/jcm12051960
_version_ 1784904771261431808
author Ma, Yibo
Hu, Miaoyang
Guo, Lanyan
Xu, Jian
Li, Jie
Yan, Qun
Pang, Huani
Wang, Jinshui
Yang, Ping
Yi, Fu
author_facet Ma, Yibo
Hu, Miaoyang
Guo, Lanyan
Xu, Jian
Li, Jie
Yan, Qun
Pang, Huani
Wang, Jinshui
Yang, Ping
Yi, Fu
author_sort Ma, Yibo
collection PubMed
description Background: Ethanol infusion in the vein of Marshall (EI-VOM) has the advantages of reducing the burden of atrial fibrillation (AF), decreasing AF recurrence, and facilitating left pulmonary vein isolation and mitral isthmus bidirectional conduction block. Moreover, it can lead to prominent edema of the coumadin ridge and atrial infarction. Whether these lesions will affect the efficacy and safety of left atrial appendage occlusion (LAAO) has not yet been reported. Objectives: To explore the clinical outcome of EI-VOM on LAAO during implantation and after 60 days of follow-up. Methods: A total of 100 consecutive patients who underwent radiofrequency catheter ablation combined with LAAO were enrolled in this study. Patients who also underwent EI-VOM at the same period of LAAO were assigned to group 1 (n = 26), and those who did not undergo EI-VOM were assigned to group 2 (n = 74). The feasibility outcomes included intra-procedural LAAO parameters and follow-up LAAO results involving device-related thrombus, a peri-device leak (PDL), and adequate occlusion (defined as a PDL ≤ 5 mm). Safety outcomes were defined as the composites of severe adverse events and cardiac function. Outpatient follow-up was performed 60 days post-procedure. Results: Intra-procedural LAAO parameters, including the rate of device reselection, rate of device redeployment, rate of intra-procedural PDLs, and total LAAO time, were comparable between groups. Furthermore, intra-procedural adequate occlusion was achieved in all patients. After a median of 68 days, 94 (94.0%) patients received their first radiographic examination. Device-related thrombus was not detected in the follow-up populations. The incidence of follow-up PDLs was similar between the two groups (28.0% vs. 33.3%, p = 0.803). The incidence of adequate occlusion was comparable between groups (96.0% vs. 98.6%, p = 0.463). In group 1, none of the patients experienced severe adverse events. Ethanol infusion significantly reduced the right atrial diameter. Conclusions: The present study showed that undergoing an EI-VOM procedure did not impact the operation or effectiveness of LAAO. Combining EI-VOM with LAAO was safe and effective.
format Online
Article
Text
id pubmed-10004188
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-100041882023-03-11 Clinical Influence of Ethanol Infusion in the Vein of Marshall on Left Atrial Appendage Occlusion: Results of Feasibility and Safety during Implantation and at 60-Day Follow-Up Ma, Yibo Hu, Miaoyang Guo, Lanyan Xu, Jian Li, Jie Yan, Qun Pang, Huani Wang, Jinshui Yang, Ping Yi, Fu J Clin Med Article Background: Ethanol infusion in the vein of Marshall (EI-VOM) has the advantages of reducing the burden of atrial fibrillation (AF), decreasing AF recurrence, and facilitating left pulmonary vein isolation and mitral isthmus bidirectional conduction block. Moreover, it can lead to prominent edema of the coumadin ridge and atrial infarction. Whether these lesions will affect the efficacy and safety of left atrial appendage occlusion (LAAO) has not yet been reported. Objectives: To explore the clinical outcome of EI-VOM on LAAO during implantation and after 60 days of follow-up. Methods: A total of 100 consecutive patients who underwent radiofrequency catheter ablation combined with LAAO were enrolled in this study. Patients who also underwent EI-VOM at the same period of LAAO were assigned to group 1 (n = 26), and those who did not undergo EI-VOM were assigned to group 2 (n = 74). The feasibility outcomes included intra-procedural LAAO parameters and follow-up LAAO results involving device-related thrombus, a peri-device leak (PDL), and adequate occlusion (defined as a PDL ≤ 5 mm). Safety outcomes were defined as the composites of severe adverse events and cardiac function. Outpatient follow-up was performed 60 days post-procedure. Results: Intra-procedural LAAO parameters, including the rate of device reselection, rate of device redeployment, rate of intra-procedural PDLs, and total LAAO time, were comparable between groups. Furthermore, intra-procedural adequate occlusion was achieved in all patients. After a median of 68 days, 94 (94.0%) patients received their first radiographic examination. Device-related thrombus was not detected in the follow-up populations. The incidence of follow-up PDLs was similar between the two groups (28.0% vs. 33.3%, p = 0.803). The incidence of adequate occlusion was comparable between groups (96.0% vs. 98.6%, p = 0.463). In group 1, none of the patients experienced severe adverse events. Ethanol infusion significantly reduced the right atrial diameter. Conclusions: The present study showed that undergoing an EI-VOM procedure did not impact the operation or effectiveness of LAAO. Combining EI-VOM with LAAO was safe and effective. MDPI 2023-03-01 /pmc/articles/PMC10004188/ /pubmed/36902746 http://dx.doi.org/10.3390/jcm12051960 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Ma, Yibo
Hu, Miaoyang
Guo, Lanyan
Xu, Jian
Li, Jie
Yan, Qun
Pang, Huani
Wang, Jinshui
Yang, Ping
Yi, Fu
Clinical Influence of Ethanol Infusion in the Vein of Marshall on Left Atrial Appendage Occlusion: Results of Feasibility and Safety during Implantation and at 60-Day Follow-Up
title Clinical Influence of Ethanol Infusion in the Vein of Marshall on Left Atrial Appendage Occlusion: Results of Feasibility and Safety during Implantation and at 60-Day Follow-Up
title_full Clinical Influence of Ethanol Infusion in the Vein of Marshall on Left Atrial Appendage Occlusion: Results of Feasibility and Safety during Implantation and at 60-Day Follow-Up
title_fullStr Clinical Influence of Ethanol Infusion in the Vein of Marshall on Left Atrial Appendage Occlusion: Results of Feasibility and Safety during Implantation and at 60-Day Follow-Up
title_full_unstemmed Clinical Influence of Ethanol Infusion in the Vein of Marshall on Left Atrial Appendage Occlusion: Results of Feasibility and Safety during Implantation and at 60-Day Follow-Up
title_short Clinical Influence of Ethanol Infusion in the Vein of Marshall on Left Atrial Appendage Occlusion: Results of Feasibility and Safety during Implantation and at 60-Day Follow-Up
title_sort clinical influence of ethanol infusion in the vein of marshall on left atrial appendage occlusion: results of feasibility and safety during implantation and at 60-day follow-up
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10004188/
https://www.ncbi.nlm.nih.gov/pubmed/36902746
http://dx.doi.org/10.3390/jcm12051960
work_keys_str_mv AT mayibo clinicalinfluenceofethanolinfusionintheveinofmarshallonleftatrialappendageocclusionresultsoffeasibilityandsafetyduringimplantationandat60dayfollowup
AT humiaoyang clinicalinfluenceofethanolinfusionintheveinofmarshallonleftatrialappendageocclusionresultsoffeasibilityandsafetyduringimplantationandat60dayfollowup
AT guolanyan clinicalinfluenceofethanolinfusionintheveinofmarshallonleftatrialappendageocclusionresultsoffeasibilityandsafetyduringimplantationandat60dayfollowup
AT xujian clinicalinfluenceofethanolinfusionintheveinofmarshallonleftatrialappendageocclusionresultsoffeasibilityandsafetyduringimplantationandat60dayfollowup
AT lijie clinicalinfluenceofethanolinfusionintheveinofmarshallonleftatrialappendageocclusionresultsoffeasibilityandsafetyduringimplantationandat60dayfollowup
AT yanqun clinicalinfluenceofethanolinfusionintheveinofmarshallonleftatrialappendageocclusionresultsoffeasibilityandsafetyduringimplantationandat60dayfollowup
AT panghuani clinicalinfluenceofethanolinfusionintheveinofmarshallonleftatrialappendageocclusionresultsoffeasibilityandsafetyduringimplantationandat60dayfollowup
AT wangjinshui clinicalinfluenceofethanolinfusionintheveinofmarshallonleftatrialappendageocclusionresultsoffeasibilityandsafetyduringimplantationandat60dayfollowup
AT yangping clinicalinfluenceofethanolinfusionintheveinofmarshallonleftatrialappendageocclusionresultsoffeasibilityandsafetyduringimplantationandat60dayfollowup
AT yifu clinicalinfluenceofethanolinfusionintheveinofmarshallonleftatrialappendageocclusionresultsoffeasibilityandsafetyduringimplantationandat60dayfollowup